Effect of melatonin on calyculin A-induced tau hyperphosphorylation

被引:57
作者
Li, XC [1 ]
Wang, ZF [1 ]
Zhang, JX [1 ]
Wang, Q [1 ]
Wang, HZ [1 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Med Coll, Inst Neurosci, Dept Pathophysiol, Wuhan 430030, Peoples R China
基金
中国国家自然科学基金;
关键词
Alzheimer disease; calyculin A; tau; phosphorylation; melatonin;
D O I
10.1016/j.ejphar.2005.01.023
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We have found in the present study that incubation of neuroblastma N2a with calyculin A, an inhibitor of protein phosphatase-2A (PP-2A) and protein phosphatase-1 (PP-1), reduces cell viability in a dose-dependent manner, and leads to tau hyperphosphorylation at tau-1 (Ser198/ 199/202) and PHF-1 (Ser396/404) epitopes. In addition to inhibit PP-2A, calyculin A treatment also results in significant activation of glycogen synthase kinase-3 (GSK-3). Calyculin A induces oxidative stress manifested by elevated level of malondialdehyde and decreased activity of superoxide dismutase. When the cells were incubated simultaneously with calyculin A and melatonin (25 mu M or 50 mu M), the calyculin A-induced decrease in cell viability, tau hyperphosphorylation, PP-2A/GSK-3 imbalance and oxidative stress were attenuated accordingly. These results suggest (i) that calyculin A induces tau hyperphosphorylation not only by inhibition of PP-2A, but also by activation of GSK-3 in N2a cells; (ii) that melatonin efficiently attenuates the calyculin A-induced damages through not only its antioxidant effect but also its modulation to the phosphorylation system. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:25 / 30
页数:6
相关论文
共 32 条
[1]  
Acuna-Castroviejo D, 1997, LIFE SCI, V60, pL23
[2]   Melatonin prevents cytoskeletal alterations and oxidative stress induced by okadaic acid in N1E-115 cells [J].
Benitez-King, G ;
Túnez, I ;
Bellon, A ;
Ortíz, GG ;
Antón-Tay, F .
EXPERIMENTAL NEUROLOGY, 2003, 182 (01) :151-159
[3]   Protein-bound acrolein: A novel marker of oxidative stress in Alzheimer's disease [J].
Calingasan, NY ;
Uchida, K ;
Gibson, GE .
JOURNAL OF NEUROCHEMISTRY, 1999, 72 (02) :751-756
[4]   Differential inhibition and posttranslational modification of protein phosphatase 1 and 2A in MCF7 cells treated with calyculin-A, okadaic acid, and tautomycine [J].
Favre, B ;
Turowski, P ;
Hemmings, BA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (21) :13856-13863
[5]  
GODERT M, 1992, NEURON, V8, P159
[6]   Effect of the lipid peroxidation product acrolein on tau phosphorylation in neural cells [J].
Gómez-Ramos, A ;
Díaz-Nido, J ;
Smith, MA ;
Perry, G ;
Avila, J .
JOURNAL OF NEUROSCIENCE RESEARCH, 2003, 71 (06) :863-870
[7]   PHOSPHOPROTEIN PHOSPHATASE-ACTIVITIES IN ALZHEIMER-DISEASE BRAIN [J].
GONG, CX ;
SINGH, TJ ;
GRUNDKEIQBAL, I ;
IQBAL, K .
JOURNAL OF NEUROCHEMISTRY, 1993, 61 (03) :921-927
[8]  
GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084
[9]   CALYCULIN-A AND OKADAIC ACID - INHIBITORS OF PROTEIN PHOSPHATASE-ACTIVITY [J].
ISHIHARA, H ;
MARTIN, BL ;
BRAUTIGAN, DL ;
KARAKI, H ;
OZAKI, H ;
KATO, Y ;
FUSETANI, N ;
WATABE, S ;
HASHIMOTO, K ;
UEMURA, D ;
HARTSHORNE, DJ .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 159 (03) :871-877
[10]   FETAL-TYPE PHOSPHORYLATION OF THE TAU IN PAIRED HELICAL FILAMENTS [J].
KANEMARU, K ;
TAKIO, K ;
MIURA, R ;
TITANI, K ;
IHARA, Y .
JOURNAL OF NEUROCHEMISTRY, 1992, 58 (05) :1667-1675